거대 다점성 흑자모반에서 발생한 다발성 스피츠 모반 1예

최준,정의창 대한피부과학회 2003 大韓皮膚科學會誌 Vol.41 No.11

Speckled lentiginous nevus is circumscribed patch of hyperpigmentation with smaller, darker pigmented macules or papules within the patch. The background shows histologic features of lentigo simplex. The speckled areas show junctional or compound nevus. Association of speckled lentiginous nevus with multiple spitz nevi was rarely reported. We report a case of multiple spitz nevi arising in a giant speckled lentiginous nevus. (Korean J Dermatol 2003;41(11) : 1568-1570)

에크린 혈관종성 과오종 1예

최준,정의창 대한피부과학회 2003 大韓皮膚科學會誌 Vol.41 No.7

Eccrine angiomatous hamartoma is a rare condition characterized histologically by increased numbers of eccrine structures and numerous capillary channels. It may be congenital or appear later in childhood. It rarely arises during puberty or adulthood. We report a case of eccrine angiomatous hamartoma on the left shoulder in a 34-year-old man. The patient presented with asymptomatic, dome-shaped, about 3 × 2.5 cm, reddish telangiectatic nodule on the left shoulder. Histological examination showed an increased numbers of eccrine sweat glands and vascular structures. (Korean J Dermatol 2003;41(7) : ?951~953)

영양소제거 공정의 기질 정량관계에 대한 온도와 기질부하의 영향

하준수,최의소,박재홍,길경익,김성원 대한상하수도학회 2003 상하수도학회지 Vol.17 No.6

This research has been performed to evaluate the stoichiometric relationship between removed COD and nitrogen or phosphorus. A modified A²/O process, which was equipped with an external nitrification tank and a switching reactor, was operated with a capacity of 50㎥/d. From the results, it has been concluded that the stoichiometric values were varied by temperature condition or input COD loads. In case of denitirfication, the requirement g COD for removed nitrate nitrogen ranged 0.13 to 10.5g, and the compensation coefficient of temperature was evaluated as 1.028. For phosphorus removal, the required COD was about 7.5gCOD_(consumed)/gP_(released) and 0.54gPHACOD_(storage)/gP_(uptake). During rainy season, as it appeared a lower organic substrate loads, the PHA(Poly Hydroxy Alkanoate) contents of biomass was reduced. From the relationship between influent BOD, and the sum of removed TN and TP, the ratio for rainy and winter season was about 4.8 and 5.8g BOD/g (TN+TP) each others. Therefor, the substrat ratios for nitrogen and phosphorus removal appeared to be affected by temperature and influent organic substrate loads.

충남 서북부지역의 개발 잠재력 분석 : 아산시를 중심으로

배성의,박동진,윤준상,황인극,최승철 공주대학교산업개발연구소 2000 産業開發硏究 Vol.8 No.-

This study was purpose for develop potential analysis of Chungnam north-west area and propose to regional development strategy. To arrived at a result for develop direction of Chungnam north-west area, Asan city will be development of central city for Asan bay, new indusrial city, tourist industrial city and ecological city.

급성골수성백혈병 환자에서 DAV 병용화학요법 후의 장기생존율

김삼용,최지영,윤환중,전의건,길준영,조덕연 충남대학교 의과대학 지역사회의학연구소 1993 충남의대잡지 Vol.20 No.2

Background : Despite substantial progress, the treatment of acute myeloid leukemia(AML) has produced complete remission in 60-80% of patients receiving induction chemotherapy, and median remission duration is about 12 months and only 20% to 35% of patients undergoing consolidation chemotherapy achieve long-term disease-free survival(DFS). We evaluated the long-term outcome of AML patients treated with doxorubicin/Ara-C/VP-16(DAV) induction chemotherapy and consolidation/intensification therapy. Method : Induction therapy : From January 1986 to December 1991, twenty three patients with previously untreated acute myelogenous leukemia received a course of 45mg/㎡ doxorubicin daily intravenously for three consecutive days with Ara-C at 100mg/㎡ by continuous intravenous infusion for eight consecutive days and VP-16 at 100mg/㎡ daily intravenously for three consecutive days. A second course of treatment was started if leukemia persisted on 22 days after treatment. Post-remission therapy : Three to six cycles were given at three or four months interval with Ara-C/doxorubicin/VP-16 regimen or other therapy. Results : Twenty two pateints were evaluable and complete remission was achieved in 16 of 22(73%). Median duration of complete remission was 8 months. The relapse rate was 81% and 63% relapsed in first year. 4-year survival rate of patients entering complete remission(n=16) was 19% and median survival duration was 14.5 months. The postremission chemotherapy was the only significant prognostic factor influencing long term disease free survival. No significant correlation was observed between the probability of survival and age (40< or >40), sex, FAR subgroup, and leukocyte count at diagnosis. The median survival duration were 21 months and 12.5 months for patients who received, or not received postremission chemotherapy respectively(P=0.035). Conclusion : Our results show that DAV combination chemotherapy is a useful therapeutic regimen in remission induction and postremission chemotherapy offering survival advantage in patients with AML entering complete remission.

급성골수백혈병에 대한 관해유도화학요법 후의 Granulocyte Colony-stimulating Factor의 효과

윤환중,최지영,전의건,길준영,조덕연,김삼용 충남대학교 의과대학 지역사회의학연구소 1993 충남의대잡지 Vol.20 No.2

Granulocyte colony-stimulating factor(G-CSF) have been shown to hasten the recovery of neutropenia following anti-cancer chemotherapy. There are controversial opinions on the use of G-CSF in acute myelogenous leukemia(AML) because clonogenic studies have shown that G-CSF stimulates leukemic colonies as well as granulocyte colonies. In this study, we evaluated the effectiveness and safety of recombinant human G-CSF after induction chemotherapy with DAV regimen(Ara-C 100mg/㎡ day 1-8, Doxorubicin 45mg/㎡ day 3-5, VP-16 100mg/㎡ day 6-8) in 9 patients with AML. G-CSF therapy(200 ㎍/㎡/day) was begun 2 days after the end of chemotherapy and continued for 10 days. 17 AML patients who recieved the same chemotherapy before the onset of this study were used as historical control. G-CSF shortened the duration of granulocytopenia (less than 500/㎣) significantly (13 vs 23 days, p<0.001), but it had no effect on platelet recovery. Although the incidence of febrile episodes was almost the same, the duration of febrile episodes was shorter in the group treated with G-CSF( 5 vs 12 days, p=0.03). There was no evidence that G-CSF accelerated the regrowth of leukemic cells and the complete remission rates between the 2 groups were not different. These results show that G-CSF accelerates the recovery of granulocytopenia and shortens the febrile days after chemotherpy in patients with AML, without affecting the regrowth of leukemic cells.

골격계의 원발성, 전이성 혈관외피세포종 : 증례 보고

김동수,김용민,최의성,손현철,박경진,조병기,이형준 충북대학교 의과대학 충북대학교 의학연구소 2009 忠北醫大學術誌 Vol.19 No.2

혈관악성종양은 혈관내피종(hemangioendothelioma), 혈관육종(angiosarcoma), 혈관외피세포종(hemangio pericytoma) 및 카포지 육종(Kposi's sarcoma) 등이 있으며, 이 중 혈관외피세포종은 비전형적인 외피 세포가 증식된 경우를 말한다. 골의 혈관외피세포종은 드문 악성종양으로 문헌상 보고되어 있는 예들은 주로 성인의 대퇴골, 골반골에 발생된 경우이다. 이 경우 원발성은 드물며 주로 비골격계에서 기원하여 골로 전이되어 발생하는 것으로 알려져 있다. 남녀 발생 빈도는 거의 동일하며, 12세부터 90세까지 어느 연령층에서도 발생할 수 있으나, 호발 연령은 40대에서 50대 사이 이다. 대개 연부조직 종양으로 신체 어디에서도 일어날 수 있고, 하지 특히 서혜부 및 대퇴부에서 가장 많이 발생하며, 후복막, 두경부 및 흉복부의 순으로 나타난다. 전이도 빈번하게 발생하는데, 그 경로는 주로 혈행성으로, 발생부위는 폐와 골이 제일 많다. 저자들은 8년 전, 우측 아래턱의 원발성 혈관외피세포종으로 절제술을 시행한 환자에서 술후 3년 뒤, 우 경골 근위부에 원격 전이가 발생하여 절제술, 예방적 골수강내 금속정 삽입술 및 골시멘트 충전술을 시행하였다. 현재 2차 수술 후 5년여가 경과한 상태로 경골에 재발의 증거가 없어 만족할 결과를 가져다주었다고 판단하여 문헌 고찰과 함께 보고하는 바이다. Hemangiopericytoma is a rare tumor of blood vessels, first described and named by Stout and Murray in 1942, arising from the contractile, elongated cells the pericytes of Zimmermann which surround capillaries. It can develop whereever there are capillaries and mostly in the connective tissue of the human body. It can also develop in any age from 12 to 90 years, and the rate of metastasis and prognosis depend on its histologic grade. We report a case of hemangiopericytoma metastasized to the right proximal tibia from the right mandible, resected three years ago. The hemangiopericytoma is a extremely rare primary malignant tumor in the bone and bone to bone metastasis is never been found in the literature before. So, we report this case and also report the good result.

강력한 운동부하후 혈중 젖산농도에 대한 성차의 비교

김학렬,조현철,최용준,김의영,안병근 龍仁大學校 體育科學硏究所 1995 體育科學硏究論叢 Vol.5 No.1

The purpose of this study was to compare sex differences of blood lactate concentration after strenous 800m sprint running and recovery 15 min. Trained-middle distance runners(Male:11, Female:10) participated as subjects of this paper. All subjects was performed a 800m sprint running, repeatedly. Blood samples for analysis a blood lactate concentration was collected in rest, warm-up after, lst 800m run after, recovery 15 min and 2nd 800m run after, respectively. The results and conclusion of this study was obtained as follows : 1. Male 800m best record in lst and 2nd run was shown a significantly high record, compared to female(lst: p<0.01, 2nd: p<0.001). 2. Blood lactate concentration after lst and 2nd run was not significant difference between male and female. However, Blood lactate concentration of both group displayed more high levels in 2nd run than lst run(p<0.001, respectively). 3. Blood lactate concentration of recovery phase was shown a significantly high lactate removal ability in male, compared with female(p<0.001). As results of above, Peak blood lactate concentration of male and female was not significant difference, but, male was shown a faster lactate removal ability compared with female.

Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax® in healthy adults aged 50 years and older

Choi, Won Suk,Choi, Jung Hyun,Jung, Dong Sik,Choi, Hee Jung,Kim, Yeon-Sook,Lee, Jacob,Jang, Hee-Chang,Shin, Eui-Cheol,Park, Jun-Sik,Kim, Hun,Cheong, Hee Jin Elsevier 2019 Vaccine Vol.37 No.27

<P><B>Abstract</B></P> <P>A multi-centre, randomised, double-blinded, active-controlled, parallel-group clinical trial was carried out to assess the immunogenicity and safety of NBP608—a newly developed live-attenuated zoster vaccine in Korea—relative to Zostavax® in healthy adults aged 50 years or older. Immune responses to the vaccine were evaluated by glycoprotein enzyme-linked immunosorbent assay (gpELISA) and enzyme-linked immunosorbent spot (ELISPOT) assays using the interferon (IFN)-γ and interleukin (IL)-2 FluoroSpot kit 6 weeks after vaccination. Safety was monitored for 26 weeks based on subjects’ diaries, spontaneous reports from subjects, and history taking by the investigators. A total of 845 subjects participated in the screening, and 823 received the vaccination (413 in the NBP608 group and 411 in the comparator group). The gpELISA-determined geometric mean fold rise from baseline to post NBP608 vaccination was 2.75 [95% confidence interval, CI (2.57, 2.94)]. The gpELISA-determined adjusted geometric mean titers (GMTs) of NBP608 and the comparator were 1346.37 [95% CI (1273.99, 1422.87)] and 1674.94 [95% CI (1585.35, 1769.58)], respectively. The adjusted GMT ratio of NBP608 to the comparator was 0.80 [95% CI (0.75, 0.87)]. There was no statistically significant difference between two groups in terms of the geometric mean spot numbers determined by IFN-γ and IL-2 ELISPOT assays at 6 weeks post vaccination (P = 0.7232, 0.3844). The incidence of adverse events (AEs) within 6 weeks post vaccination was 49.82% overall (410/823, 941 cases), 50.73% (209/412, 474 cases) in the NBP608 group, and 48.91% (201/411, 467 cases) in the comparator group. The difference in AE rate between the two groups was not statistically significant (P = 0.6010). Most AEs were mild, with a rate of 83.12% in the NBP608 group and 75.37% in the comparator group. Thus, NBP608 is non-inferior to Zostavax® in terms of inducing the immune response and can be safely administered to adults aged 50 years or older.</P> <P>ClinicalTrials.gov Identifier: NCT03120364.</P>

영랑호 어류군집의 시,공간적 분포

최의용 ( Eui Yong Choi ),최재석 ( Jae Seok Choi ),박승철 ( Seung Chul Park ),장영수 ( Yong Su Jang ),이광열 ( Kwang Yeol Lee ),최준길 ( Jun Kil Choi ) 한국환경생태학회 2007 한국환경생태학회지 Vol.21 No.6